MENU
NUVB
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Nuvation Bio (NUVB) Ownership - Who owns Nuvation Bio?

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more

Profile

Industry
N/A
Address
1500 Broadway
Phone
+1 332 208-6102
Employees
51
Web
https://www.nuvationbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.89B
P/E Ratio
N/A
Total Cash
549.05M
Projected Growth
N/A
Total Debt
57.55M
Revenue
26.75M
Risk (Beta)
2.65
Dividend Yield
N/A
Total Cash/Share
1.60
Total Debt/Equity
N/A
Revenue/Share
0.08 USD as % of share price

Fundamentals

NUVB
Capitalization
2.89B
P/E Ratio
N/A
Risk (Beta)
2.65
Dividend Yield
N/A
Total Cash
549M
Total Cash/Share
1.60
Total Debt
57.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.08%
Revenue
26.7M
ROE
N/A
Book Value
326M
P/B Ratio
8.87
Cash Flow
N/A
Earnings
-0.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.41B
Current Ratio
8.48
Current Revenue Per Employee
45085.91
Dividends Per Share - Security
N/A
EBITDA
-208.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
74.47
Revenue To Assets
-37.08
Shares Held By Institutions
1.61B
Shares Outstanding - Current
343M
Total Liabilities
276M
Total Volume MTD
N/A
Value
N/A
Gain YTD
210.902
View a ticker or compare two or three
NUVB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NUVB showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1500 Broadway
Phone
+1 332 208-6102
Employees
51
Web
https://www.nuvationbio.com